Evolution Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5K Hold
11
﹤0.01% 142
2025
Q4
$5K Sell
11
-344
-97% -$160K ﹤0.01% 150
2025
Q3
$151K Hold
355
0.07% 49
2025
Q2
$136K Sell
355
-35
-9% -$12.6K 0.07% 50
2025
Q1
$134K Hold
390
0.07% 51
2024
Q4
$117K Sell
390
-77
-16% -$26.9K 0.06% 52
2024
Q3
$189K Buy
467
+379
+431% +$139K 0.1% 40
2024
Q2
$28K Hold
88
0.02% 106
2024
Q1
$30K Hold
88
0.02% 110
2023
Q4
$24K Sell
88
-77
-47% -$19K 0.02% 119
2023
Q3
$40K Hold
165
0.03% 70
2023
Q2
$50K Hold
165
0.04% 65
2023
Q1
$43K Hold
165
0.03% 64
2022
Q4
$39K Sell
165
-150
-48% -$33.6K 0.03% 72
2022
Q3
$57K Hold
315
0.05% 55
2022
Q2
$55K Hold
315
0.04% 57
2022
Q1
$78K Hold
315
0.06% 52
2021
Q4
$80K Buy
+315
New +$77.1K 0.06% 44

Other funds holding HCA

Evolution Advisers's HCA Position: Q1 2026 in Review

Evolution Advisers held its HCA Healthcare (HCA) position steady in Q1 2026 at 11 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #142.

Evolution Advisers first reported a position in HCA in Q4 2021 and has held it in 18 quarters since. The position peaked at $189K in Q3 2024. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Evolution Advisers held 11 shares of HCA Healthcare worth $5K as of Q1 2026.
  • Evolution Advisers left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up ﹤0.01% of Evolution Advisers's portfolio in Q1 2026, its #142 holding.
  • Evolution Advisers first reported a position in HCA Healthcare in Q4 2021 and has held it in 18 quarters since.
  • Evolution Advisers's HCA Healthcare position peaked at $189K in Q3 2024.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Evolution Advisers's 13F filing for Q1 2026, filed 1 May 2026.